Oncology Corporate Profile
Celyad is a clinical-stage biopharmaceutical company focused on the identification and development of specialized cell based therapies. With product candidates in oncology and cardiology, Celyad seeks to address diseases with high unmet medical needs such as heart failure and cancer. Founded in 2007, Celyad leverages unique know-how in taking cell based therapies from bench to Phase III, as well as the manufacturing and logistical infrastructure for such complex products.
|Brand / Product||Class||Area of Study||Phase||Partnership|
|CAR-T NKR-3||NKG2D CAR T-cell therapy||Various cancer types||I|
|CAR-T NKR-2||NKG2D CAR T-cell therapy||Various cancer types||I|
|CAR-T NKR-3||NKG2D CAR T-cell therapy||Various cancer types||Preclinical|
|CAR-T B7H6||NKG2D CAR T-cell therapy||Various cancer types||Preclinical|